1 Awiwi MO,Vikram R.Radiologic diagnosis and staging of bladder cancer:an update[J].J Comput Assist Tomogr,2022,46(4):530-544. 2 Lobo N,Afferi L,Moschini M,et al.Epidemiology,screening,and prevention of bladder cancer[J].Eur Urol Oncol,2022,5(6):628-639. 3 Marqués M,Corral S,Sánchez-Díaz M,et al.Tumor and stromal cell targeting with nintedanib and alpelisib overcomes intrinsic bladder cancer resistance[J].Mol Cancer Ther,2023,22(5):616-629. 4 Zhang Z,Chen F,Zhan H,et al.LncRNA CASC9 sponges miR-758-3p to promote proliferation and EMT in bladder cancer by upregulating TGF-β2[J].Oncol Rep,2021,45(1):265-277. 5 Li Q,Huyan T,Cai S,et al.The role of exosomal miR-375-3p:A potential suppressor in bladder cancer via the Wnt/β-catenin pathway[J].FASEB J,2020,34(9):12177-12196. 6 Huang G,Guo X,Yang H.Long noncoding RNA SNHG1 promotes human prostate cancer progression by sponging miR-383-5p[J].Anticancer Drugs,2021,32(3):286-295. 7 Liu Y,Yu H,Zeng B,et al.MiR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway[J].Cancer Biomark,2023,37(2):121-131. 8 Gao D,Nyalali AMK,Hou Y,et al.2,5-Dimethyl celecoxib inhibits proliferation and cell cycle and induces apoptosis in glioblastoma by suppressing CIP2A/PP2A /Akt signaling axis[J].J Mol Neurosci,2021,71(8):1703-1713. 9 Gao F,Xu T,Wang X,et al.CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin[J].J Exp Clin Cancer Res,2017,36(1):70. 10 Li X,Yuan J,Cao Q,et al.MicroRNA-383-5p inhibits the proliferation and promotes the apoptosis of gastric cancer cells by targeting cancerous inhibitor of PP2A[J].Int J Mol Med,2020,46(1):397-405. 11 Hoeh B,Flammia RS,Hohenhorst L,et al.Outcomes of robotic-assisted versus open radical cystectomy in a large-scale,contemporary cohort of bladder cancer patients[J].J Surg Oncol,2022,126(4):830-837. 12 Verma A,Kapoor R,Mittal RD.Cluster of differentiation 44(CD44)gene variants:a putative cancer stem cell marker in risk prediction of bladder cancer in north indian population[J].Indian J Clin Biochem,2017,32(1):74-83. 13 Xiang W,Lyu L,Huang T,et al.The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2[J].J Cell Mol Med,2020,24(20):11858-11873. 14 Gao Z,Li S,Zhou X,et al.Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1[J].Cancer Med,2020,9(20):7695- 7705. 15 Wang W,Liu Z,Zhang X,et al.miR-211-5p is down-regulated and a prognostic marker in bladder cancer[J].J Gene Med,2020,22(12):e3270. 16 Wei C,Gao JJ.Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis[J].Peer J,2019,7:e7882. 17 Hu Y,Ma Y,Liu J,et al.LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis[J].BMC Cancer,2019,19(1):1157. 18 Shao B,Fu X,Li X,et al.RP11-284F21.9 promotes oral squamous cell carcinoma development via the miR-383-5p/MAL2 axis[J].J Oral Pathol Med,2020,49(1):21-29. 19 Jiang J,Xie C,Liu Y,et al.Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27[J].Biomed Pharmacother,2019,109:595-601. 20 Liu CY,Huang TT,Chen YT,et al.Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression[J].EBioMedicine,2019,40:263-275. 21 Clark RE,Basabrain AA,Austin GM,et al.Validation of CIP2A as a biomarker of subsequent disease progression and treatment failure in chronic myeloid leukaemia[J].Cancers(Basel),2021,13(9):2155. 22 Wu J,Ye F,Xu T.Celastrol impairs tumor growth by modulating the CIP2A-GSK3β- MCL-1 axis in gastric cancer cells[J].Aging(Albany NY),2023,15(14):6894-6904. 23 向雨晨,杨锐,周彤,等.重楼皂苷Ⅰ通过下调CIP2A/PP2A/ERK信号通路抑制前列腺癌转移的机制研究[J].湖北医药学院学报,2019,38(3):201-208. 24 许智星.CIP2A在胶质瘤中的表达及其对细胞增殖、侵袭、迁移的影响[D].昆明:昆明医科大学,2020. |